Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Friday 01 March, 2013

AIM

Schedule 1 - CloudTag Inc

RNS Number : 0139Z
AIM
01 March 2013
 



ANNOUNCEMENT TO BE MADE BY THE AIM APPLICANT PRIOR TO ADMISSION IN ACCORDANCE WITH RULE 2 OF THE AIM RULES FOR COMPANIES ("AIM RULES")

 

COMPANY NAME:

CloudTag Inc. ("CloudTag")

 

COMPANY REGISTERED OFFICE ADDRESS AND IF DIFFERENT, COMPANY TRADING ADDRESS (INCLUDING POSTCODES) :

Registered office: Zephyr House, 122 Mary Street, P.O. Box 709, KY1-1107 Grand Cayman, Cayman Islands

Trading address: 10 Rue de Simplon, 1207 Geneva, Switzerland

 

COUNTRY OF INCORPORATION:

Cayman Islands

 

COMPANY WEBSITE ADDRESS CONTAINING ALL INFORMATION REQUIRED BY AIM RULE 26:

www.cloudtag.com

 

COMPANY BUSINESS (INCLUDING MAIN COUNTRY OF OPERATION) OR, IN THE CASE OF AN INVESTING COMPANY, DETAILS OF ITS INVESTING POLICY).  IF THE ADMISSION IS SOUGHT AS A RESULT OF A REVERSE TAKE-OVER UNDER RULE 14, THIS SHOULD BE STATED:

 

CloudTag's business is to develop, market and sell a physiological monitoring technology to the professional sports, consumer wellbeing and weight-loss markets. The Group has engaged highly experienced industry leaders from the fields of software and hardware technology development, medical innovation and professional fitness to develop a new and innovative product.

The CloudTag product, once launched, will combine clinical-grade ECG technology and digital hardware to be worn as a patch on the body, with software applications and Cloud infrastructure. Together, this will provide a wireless physiological monitoring technology that will record and supply clinical-grade data to users, in real-time, via a bespoke software application and user interface developed by Preciousbluedot, and accessible via internet enabled devices such as smartphones and tablets.

DETAILS OF SECURITIES TO BE ADMITTED INCLUDING ANY RESTRICTIONS AS TO TRANSFER OF THE SECURITIES (i.e. where known, number and type of shares, nominal value and issue price to which it seeks admission and the number and type to be held as treasury shares):

·     TBC New Ordinary Shares

·     Nominal value of 0.1p (one tenth of a penny)

·     Issue price of 20.0p

·     No shares to be held as treasury shares

 

CAPITAL TO BE RAISED ON ADMISSION (IF APPLICABLE) AND ANTICIPATED MARKET CAPITALISATION ON ADMISSION:

·     £TBC to be raised on Admission (before expenses)

·     Anticipated market capitalisation of c. £TBC

 

 

PERCENTAGE OF AIM SECURITIES NOT IN PUBLIC HANDS AT ADMISSION:

TBC

 

DETAILS OF ANY OTHER EXCHANGE OR TRADING PLATFORM TO WHICH THE AIM COMPANY HAS APPLIED OR AGREED TO HAVE ANY OF ITS SECURITIES (INCLUDING ITS AIM SECURITIES) ADMITTED OR TRADED:

N/A

FULL NAMES AND FUNCTIONS OF DIRECTORS AND PROPOSED DIRECTORS (underlining the first name by which each is known or including any other name by which each is known):

 

Directors:

Anthony (Tony) Henry Reeves (Non-Executive Chairman)

Andrew David Jackson (Commercial Director)

Michael Brian Victor Cudworth Hirschfield (Interim Finance Director)

Alexander Mark Butcher (Non-Executive Director)

 

FULL NAMES AND HOLDINGS OF SIGNIFICANT SHAREHOLDERS EXPRESSED AS A PERCENTAGE OF THE ISSUED SHARE CAPITAL, BEFORE AND AFTER ADMISSION (underlining the first name by which each is known or including any other name by which each is known):

 

Before Admission:

Shareholder

Number of shares held

Percentage holding

Osuna Limited

30,975,000

23.22%

Corvus Capital Limited

25,200,000

18.89%

TD Wealth Institutional (UK) Nominees Limited

15,000,000

11.24%

Ambeson Limited

11,000,000

8.25%

Mike Hirschfield

6,875,000

5.15%

Mark Betteridge

4,250,000

3.19%

Lee Musgrave

4,250,000

3.19%

Calvet International Limited

4,000,000

3.00%

 

Post Admission:

 

Shareholder

Number of shares held

Percentage holding

Osuna Limited

TBC

TBC

Corvus Capital Limited

TBC

TBC

TD Wealth Institutional (UK) Nominees Limited

TBC

TBC

Ambeson Limited

TBC

TBC

Mike Hirschfield

TBC

TBC

 

 

 

 

 

 

NAMES OF ALL PERSONS TO BE DISCLOSED IN ACCORDANCE WITH SCHEDULE 2, PARAGRAPH (H) OF THE AIM RULES:

 

(i)         ANTICIPATED ACCOUNTING REFERENCE DATE

(ii)        DATE TO WHICH THE MAIN FINANCIAL INFORMATION IN THE ADMISSION DOCUMENT HAS BEEN PREPARED (this may be represented by unaudited interim financial information)

(iii)       DATES BY WHICH IT MUST PUBLISH ITS FIRST THREE REPORTS PURSUANT TO AIM RULES 18 AND 19:

 

(i)         30 September

(ii)        30 September 2012

(iii)       31 March 2013, 30 June 2013 and 31 March 2014

 

EXPECTED ADMISSION DATE:

Mid March 2013

 

NAME AND ADDRESS OF NOMINATED ADVISER:

Strand Hanson Limited

26 Mount Row

London W1K 3SQ

 

NAME AND ADDRESS OF BROKER:

Keith, Bayley, Rogers & Co Limited

2nd Floor

Finsbury Tower

103-105 Bunhill Row

London EC18LZ

 

OTHER THAN IN THE CASE OF A QUOTED APPLICANT, DETAILS OF WHERE (POSTAL OR INTERNET ADDRESS) THE ADMISSION DOCUMENT WILL BE AVAILABLE FROM, WITH A STATEMENT THAT THIS WILL CONTAIN FULL DETAILS ABOUT THE APPLICANT AND THE ADMISSION OF ITS SECURITIES:

The admission document containing full details of the applicant and its securities will be available for public inspection for a period of not less than one month from the date of admission at the following location during normal business hours on any weekday (other than Saturdays, Sundays and public holidays):

 

Strand Hanson Limited

26 Mount Row

London W1K 3SQ

 

DATE OF NOTIFICATION:

1 March 2013

 

NEW / UPDATE:

NEW

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PAAUGUGPWUPWGUG

a d v e r t i s e m e n t